Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.13 USD | -1.66% | -7.99% | +156.43% |
May. 09 | Cullinan Therapeutics Insider Sold Shares Worth $1,796,676, According to a Recent SEC Filing | MT |
Apr. 29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
Financials (USD)
Sales 2024 * | 2.14M | Sales 2025 * | 13.04M | Capitalization | 1.13B |
---|---|---|---|---|---|
Net income 2024 * | -175M | Net income 2025 * | -189M | EV / Sales 2024 * | 236 x |
Net cash position 2024 * | 619M | Net cash position 2025 * | 538M | EV / Sales 2025 * | 45 x |
P/E ratio 2024 * |
-7.7
x | P/E ratio 2025 * |
-8.24
x | Employees | 85 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.6% |
Latest transcript on Cullinan Therapeutics, Inc.
1 day | -1.66% | ||
1 week | -7.99% | ||
Current month | -3.26% | ||
1 month | +56.75% | ||
3 months | +45.90% | ||
6 months | +197.95% | ||
Current year | +156.43% |
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 26.13 | -1.66% | 717,785 |
24-05-10 | 26.57 | -2.21% | 589,063 |
24-05-09 | 27.17 | -1.98% | 1,224,765 |
24-05-08 | 27.72 | -5.55% | 1,031,724 |
24-05-07 | 29.35 | +3.35% | 873,483 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+156.43% | 1.13B | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.49% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- CGEM Stock